亚太地区

Ropes & Gray’s veteran Asia-based attorneys bring sophisticated knowledge and on-the-ground experience to the leading technological innovators and financial dealmakers of the dynamic economies of Asia.


Awards

Ropes & Gray’s work in Asia has quickly garnered recognition by clients and independent reviewers, including:

  • Chambers Asia-Pacific, Chambers Greater China, Chambers Global, The Legal 500 Asia Pacific, IFLR 1000: Ranked year after year in the Asia-Pacific region as leaders within Greater China, Hong Kong, Japan, South Korea, and India in:
    • Banking and Finance
    • Capital Markets
    • Corporate/M&A
    • Disputes/Anti-Corruption & Compliance
    • Intellectual Property
    • Investment Funds
    • Healthcare and Life Sciences
    • Private Equity/Venture Capital
    • Regulatory/Compliance
  • India Business Law Journal 2024 – “Top Foreign Firms 2024” list.
  • China Business Law Journal’s 2024 China Business Law Awards – recognized for Healthcare, pharma & life sciences, IP (Patent), Private Equity & Venture Capital, Pro-bono.
  • Asian Legal Business’ 2024 Asia IP Rankings:
    • Patents – Tier 1 in South Korea and Tier 2 for China, Hong Kong and Japan.
    • Copyright/Trademarks – Tier 2 in China, Hong Kong and South Korea.
  • China Business Law Journal’s Deals of the Year 2023 Awards:
    • HUTCHMED’s Worldwide License Agreement with Takeda Pharmaceutical
    • Vistra and Tricor’s $6.5 billion merger
  • Asia Business Law Journal’s 2023 Korea Law Firm Awards – recognized as among Korea’s Best Foreign Law Firms.
  • India Business Law Journal 2023 – “Top Foreign Firms 2023” list.
  • China Business Law Journal’s 2023 China Business Law Awards – recognized for Asset management, IP (Patent), Healthcare, pharma & life sciences, and Pro-Bono.
  • Asian Legal Business’ ALB Japan Law Awards 2023, for Bain Capital’s $7.5 billion leveraged tender offer for Hitachi Metals (now Proterial), named winner of:
    • Debt Market Deal of the Year
    • Technology, Media and Telecommunications Deal of the Year
  • China Law & Practice Awards 2022 – “Equity Securities Deal of the Year” for LianBio IPO.
  • India Business Law Journal 2022 – “Top Foreign Firms 2022” list.
  • The Asia Legal Awards 2022:
  • China Business Law Journal Awards 2022: recognized for Pro-Bono, Asset management, IP (Patents), Private Equity & Venture Capital, Healthcare, pharma & life sciences.
  • Asian Legal Business’ 2022 Asia IP Rankings: Patents, Tier 1 among international firms in China, Hong Kong, Japan and South Korea; Trademarks and Copyright, Tier 1 among international firms in China; Trademarks and Copyright, Tier 2 among international firms in Hong Kong and South Korea.
  • Refinitiv’s Global Mergers & Acquisitions Review 2021 – ranked among the top 10 legal advisers for M&A across the Asia Pacific.
  • Asia Business Law Journal 2021 – “Top Asia-Related SPAC Legal Advisers of 2020-21” - ranked among the top 10 legal advisers to Asia-related SPACs for underwriters ranked by deal value and deal count.
  • Mergermarket Asia Pacific M&A Legal Advisers, 1H 2021 -– ranked third in league tables for Asia Pacific mergers & acquisitions legal advisers by value, excluding Japan, in 1H 2021.
  • Asian Legal Business’ 2021 IP Rankings: Patents, Tier 1 among international firms in China, Hong Kong, Japan and South Korea; Trademark and Copyright, Tier 1 in China; Trademark and Copyright, Tier 2 in Hong Kong and South Korea.
  • Asian Legal Business’ 2020 IP Rankings – Patents, Tier 1 among international firms in China, Japan, South Korea and Hong Kong.
  • China Business Law Journals2020 China Business Law Awards:
    • Practice Groups recognized: asset management, health care, pharmaceuticals & life sciences intellectual property matters, including patents.
  • Mergermarket Japan M&A Awards 2020 – named “Private Equity Legal Adviser of the Year.”
  • Asian Legal Business’ ALB Japan Law Awards 2019 – M&A Deal of the Year (Midsize): Baring Private Equity Asia’s Acquisition of Pioneer Corporation.
  • Private Equity International 2020 Awards – named among Asia’s top three law firms in for fund formation and secondaries transactions.
  • Financial Times Asia-Pacific Innovative Lawyers 2019 – praised for innovation in Enabling Business Growth and Transformation for:
    • Designing the governance structure for a joint venture between Alibaba Group and Switzerland-based luxury goods company Richemont.
    • Advising Bain Capital on its simultaneous acquisition of U.S.-based packaging company World Wide Packaging and a leading Chinese cosmetics packaging manufacturer in advance of merging the two companies.
  • IFLR Asia-Pacific Awards 2019 – “Private Equity Deal of the Year” for Bain Capital-led consortium’s $18 billion buyout of Toshiba Memory Corporation.
  • IFLR Asia-Pacific Awards 2019 – “Private Equity Team of the Year”
  • China Law & Practice 2019 Awards – “Outbound Deal of the Year” for advising Harbin Pharmaceutical’s $300 million investment in GNC Holdings.
  • China Business Law Journal’s 2019 China Business Law Awards – recognized for mergers & acquisitions, restructuring & insolvency and intellectual property, including patents.
  • Asian Legal Business’ 2019 IP Rankings – Patents, Tier 1 among international firms in China, Japan and South Korea.
  • Financial Times Asia-Pacific Innovative Lawyers 2018 – Winner for “Innovation in Legal Expertise: Managing Complexity and Scale” for Toshiba’s US$18 billion sale of its memory chip business.
  • Asian Legal Business Japan Law Awards 2018 – “M&A Deal of the Year (Premium)”, “Technology, Media and Telecommunications Deal of the Year” and “Japan Deal of the Year” for Toshiba's US$18 billion sale of its memory chip business.
  • Private Equity International 2018 Awards – named among Asia’s top three law firms for fund formation, transactions, and secondaries.
Ropes & Gray is very good, especially for highly structured matters where it is necessary to handle different stakeholders.
Chambers Asia